AFT Pharmaceuticals Limited (AFP.AX)
AUD 2.55
(-1.54%)
AUD 2.55
(-1.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 77.46 Million NZD | 3.57% |
| 2023 | 74.79 Million NZD | 15.04% |
| 2022 | 65.01 Million NZD | -5.15% |
| 2021 | 68.54 Million NZD | -1.8% |
| 2020 | 69.79 Million NZD | 19.3% |
| 2019 | 58.5 Million NZD | 18.76% |
| 2018 | 49.26 Million NZD | 26.78% |
| 2017 | 38.85 Million NZD | 4.8% |
| 2016 | 37.07 Million NZD | 18.86% |
| 2015 | 31.19 Million NZD | 39.13% |
| 2014 | 22.41 Million NZD | 25.2% |
| 2013 | 17.9 Million NZD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 77.46 Million NZD | -8.83% |
| 2024 Q2 | 84.96 Million NZD | 13.6% |
| 2024 FY | 77.46 Million NZD | 3.57% |
| 2023 Q2 | 67.88 Million NZD | 4.41% |
| 2023 FY | 74.79 Million NZD | 15.04% |
| 2023 Q4 | 74.79 Million NZD | 10.18% |
| 2022 FY | 65.01 Million NZD | -5.15% |
| 2022 Q4 | 65.01 Million NZD | 0.63% |
| 2022 Q2 | 64.61 Million NZD | -5.74% |
| 2021 FY | 68.54 Million NZD | -1.8% |
| 2021 Q2 | 64.09 Million NZD | -8.17% |
| 2021 Q4 | 68.54 Million NZD | 6.94% |
| 2020 FY | 69.79 Million NZD | 19.3% |
| 2020 Q2 | 68.64 Million NZD | 17.34% |
| 2020 Q4 | 69.79 Million NZD | 1.67% |
| 2019 Q4 | 58.5 Million NZD | 3.65% |
| 2019 FY | 58.5 Million NZD | 18.76% |
| 2019 Q2 | 56.44 Million NZD | 14.59% |
| 2018 Q4 | 49.26 Million NZD | 33.0% |
| 2018 FY | 49.26 Million NZD | 26.78% |
| 2018 Q2 | 37.03 Million NZD | -4.67% |
| 2017 FY | 38.85 Million NZD | 4.8% |
| 2017 Q2 | 35.75 Million NZD | -3.56% |
| 2017 Q4 | 38.85 Million NZD | 8.67% |
| 2016 FY | 37.07 Million NZD | 18.86% |
| 2016 Q4 | 37.07 Million NZD | 0.93% |
| 2016 Q2 | 36.73 Million NZD | 17.76% |
| 2015 FY | 31.19 Million NZD | 39.13% |
| 2015 Q4 | 31.19 Million NZD | 0.0% |
| 2014 FY | 22.41 Million NZD | 25.2% |
| 2013 FY | 17.9 Million NZD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Althea Group Holdings Limited | 23.33 Million AUD | -231.928% |
| Cann Group Limited | 78.85 Million AUD | 1.76% |
| ECS Botanics Holdings Ltd | 4.66 Million AUD | -1559.176% |
| Ecofibre Limited | 30.27 Million AUD | -155.827% |
| Elixinol Wellness Limited | 5.24 Million AUD | -1375.748% |
| Hygrovest Limited | 2.68 Million AUD | -2789.295% |
| IDT Australia Limited | 7.93 Million AUD | -876.822% |
| Invion Limited | 1.01 Million AUD | -7540.644% |
| Little Green Pharma Ltd | 16.39 Million AUD | -372.575% |
| Live Verdure Ltd | 1.95 Million AUD | -3863.641% |
| Medical Developments International Limited | 13.42 Million AUD | -476.912% |
| Vitura Health Limited | 32.83 Million AUD | -135.883% |
| Vita Life Sciences Limited | 16.47 Million AUD | -370.151% |